227 related articles for article (PubMed ID: 10452663)
1. Bacteremia due to Capnocytophaga species in patients with neutropenia: high frequency of beta-lactamase-producing strains.
Maury S; Leblanc T; Rousselot P; Legrand P; Arlet G; Cordonnier C
Clin Infect Dis; 1999 May; 28(5):1172-4. PubMed ID: 10452663
[No Abstract] [Full Text] [Related]
2. Bacteremia caused by Capnocytophaga species in patients with neutropenia and cancer: results of a multicenter study.
Martino R; Rámila E; Capdevila JA; Planes A; Rovira M; Ortega Md ; Plumé G; Gómez L; Sierra J
Clin Infect Dis; 2001 Aug; 33(4):E20-2. PubMed ID: 11462207
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial treatment of Capnocytophaga infections.
Jolivet-Gougeon A; Sixou JL; Tamanai-Shacoori Z; Bonnaure-Mallet M
Int J Antimicrob Agents; 2007 Apr; 29(4):367-73. PubMed ID: 17250994
[TBL] [Abstract][Full Text] [Related]
4. [Capnocytophaga spp. bacteremia in compromised patients].
Ramos JM; Pacho E; Bernacer M; Fernández-Roblas R; Soto C; Soriano F
Enferm Infecc Microbiol Clin; 1993 Apr; 11(4):206-9. PubMed ID: 8512974
[TBL] [Abstract][Full Text] [Related]
5. First case of bacteremia due to chromosome-encoded CfxA3-beta-lactamase-producing Capnocytophaga sputigena in a pediatric patient with acute erythroblastic leukemia.
Matsumoto T; Matsubara M; Oana K; Kasuga E; Suzuki T; Hidaka E; Shigemura T; Yamauchi K; Honda T; Ota H; Kawakami Y
Eur J Med Res; 2008 Mar; 13(3):133-5. PubMed ID: 18499560
[TBL] [Abstract][Full Text] [Related]
6. Failure of cefepime therapy in neutropenic patients with extended-spectrum beta-lactamase-producing Gram-negative bacteraemia.
Wi YM; Kang CI; Cheong HS; Chung DR; Jung CW; Ko KS; Song JH; Peck KR
Int J Antimicrob Agents; 2009 Apr; 33(4):384-6. PubMed ID: 19097866
[No Abstract] [Full Text] [Related]
7. Prevalence of oropharyngeal beta-lactamase-producing Capnocytophaga spp. in pediatric oncology patients over a ten-year period.
Jolivet-Gougeon A; Tamanai-Shacoori Z; Desbordes L; Gandemer V; Sixou JL; Morvan-Graveline N; Cormier M; Bonnaure-Mallet M
BMC Infect Dis; 2005 May; 5():32. PubMed ID: 15882453
[TBL] [Abstract][Full Text] [Related]
8. Ertapenem for the treatment of extended-spectrum beta-lactamase-producing Gram-negative bacterial infections.
Teng CP; Chen HH; Chan J; Lye DC
Int J Antimicrob Agents; 2007 Oct; 30(4):356-9. PubMed ID: 17631986
[TBL] [Abstract][Full Text] [Related]
9. Bacteremia by multidrug-resistant Capnocytophaga sputigena.
Gomez-Garces JL; Alos JI; Sanchez J; Cogollos R
J Clin Microbiol; 1994 Apr; 32(4):1067-9. PubMed ID: 8027314
[TBL] [Abstract][Full Text] [Related]
10. [Bacteremia caused by Capnocytophaga ochracea: apropos of 2 cases].
Viudes A; Orero A; Larrea L; Pérez Bellés C; Pérez de Léon A; Pérez Silvert M; Gobernado M
Enferm Infecc Microbiol Clin; 1997; 15(6):338-9. PubMed ID: 9376412
[No Abstract] [Full Text] [Related]
11. Capnocytophaga gingivalis bacteremia detected only on quantitative blood cultures in a child with leukemia.
Mantadakis E; Danilatou V; Christidou A; Stiakaki E; Kalmanti M
Pediatr Infect Dis J; 2003 Feb; 22(2):202-4. PubMed ID: 12613461
[TBL] [Abstract][Full Text] [Related]
12. Influence of previous antimicrobial therapy on oral carriage of beta-lactamase producing Capnocytophaga isolates.
Jolivet-Gougeon A; Guérin J; Tamanai-Shacoori Z; Gandemer V; Sixou JL; Bonnaure-Mallet M
Acta Paediatr; 2008 Jul; 97(7):964-7. PubMed ID: 18532936
[TBL] [Abstract][Full Text] [Related]
13. Risk factors and outcomes of bloodstream infections with metallo-beta-lactamase-producing Acinetobacter.
Kim YA; Choi JY; Kim CK; Kim CO; Kim MS; Choi SH; Chin BS; Han SH; Lee HS; Choi HK; Jeoung SJ; Song YG; Yum JH; Yong D; Lee K; Kim JM
Scand J Infect Dis; 2008; 40(3):234-40. PubMed ID: 17852898
[TBL] [Abstract][Full Text] [Related]
14. [Bacteremia due to Capnocytophaga spp.: two cases].
García J; Lizasoain M; Lahuerta JJ; Sanz F
Enferm Infecc Microbiol Clin; 2003 Mar; 21(3):168-9. PubMed ID: 12586027
[No Abstract] [Full Text] [Related]
15. Clinical experiences of bacteremia caused by metallo-beta-lactamase-producing gram-negative organisms.
Lee NY; Yan JJ; Lee HC; Liu KH; Huang ST; Ko WC
J Microbiol Immunol Infect; 2004 Dec; 37(6):343-9. PubMed ID: 15599466
[TBL] [Abstract][Full Text] [Related]
16. Microbiological spectrum and susceptibility patterns of pathogens causing bacteraemia in paediatric febrile neutropenic oncology patients: comparison between two consecutive time periods with use of different antibiotic treatment protocols.
Greenberg D; Moser A; Yagupsky P; Peled N; Hofman Y; Kapelushnik J; Leibovitz E
Int J Antimicrob Agents; 2005 Jun; 25(6):469-73. PubMed ID: 15890499
[TBL] [Abstract][Full Text] [Related]
17. [Resistance to newer beta-lactams and related ESBL types in gram-negative nosocomial isolates in Turkish hospitals: results of the multicentre HITIT study].
Gür D; Gülay Z; Akan OA; Aktaş Z; Kayacan CB; Cakici O; Eraç B; Gültekin M; Oğünç D; Söyletir G; Unal N; Uysal S
Mikrobiyol Bul; 2008 Oct; 42(4):537-44. PubMed ID: 19149074
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of extended spectrum beta-lactamase among multidrug resistant gram-negative isolates from a general hospital in Saudi Arabia.
Kader AA; Kumar AK
Saudi Med J; 2004 May; 25(5):570-4. PubMed ID: 15138522
[TBL] [Abstract][Full Text] [Related]
19. Capnocytophaga bacteremia: clinical features of patients and antimicrobial susceptibility of isolates.
Lin RD; Hsueh PR; Chang SC; Luh KT
J Formos Med Assoc; 1998 Jan; 97(1):44-8. PubMed ID: 9481064
[TBL] [Abstract][Full Text] [Related]
20. [Bacteremia due to Capnocytophaga species during chemotherapy-induced neutropenia in patients with hematological malignancies].
Murakami K; Mori T; Kato J; Shimizu T; Kohashi S; Sakurai M; Sugita K; Hasegawa N; Murata M; Okamoto S
Rinsho Ketsueki; 2017; 58(3):210-215. PubMed ID: 28381687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
